Vascular endothelial growth factor B controls endothelial fatty acid uptake
Top Cited Papers
- 14 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 464 (7290), 917-921
- https://doi.org/10.1038/nature08945
Abstract
The vascular endothelial growth factors (VEGFs) are major angiogenic regulators and are involved in several aspects of endothelial cell physiology(1). However, the detailed role of VEGF-B in blood vessel function has remained unclear(2,3). Here we show that VEGF-B has an unexpected role in endothelial targeting of lipids to peripheral tissues. Dietary lipids present in circulation have to be transported through the vascular endothelium to be metabolized by tissue cells, a mechanism that is poorly understood(4). Bioinformatic analysis showed that Vegfb was tightly co-expressed with nuclear-encoded mitochondrial genes across a large variety of physiological conditions in mice, pointing to a role for VEGF-B in metabolism. VEGF-B specifically controlled endothelial uptake of fatty acids via transcriptional regulation of vascular fatty acid transport proteins. As a consequence, Vegfb(-/-) mice showed less uptake and accumulation of lipids in muscle, heart and brown adipose tissue, and instead shunted lipids to white adipose tissue. This regulation was mediated by VEGF receptor 1 and neuropilin 1 expressed by the endothelium. The co-expression of VEGF-B and mitochondrial proteins introduces a novel regulatory mechanism, whereby endothelial lipid uptake and mitochondrial lipid use are tightly coordinated. The involvement of VEGF-B in lipid uptake may open up the possibility for novel strategies to modulate pathological lipid accumulation in diabetes, obesity and cardiovascular diseases.This publication has 37 references indexed in Scilit:
- Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent MechanismsCirculation, 2009
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nature Reviews Cancer, 2008
- Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorBlood, 2008
- Lipid‐Induced Metabolic Dysfunction in Skeletal MusclePublished by Wiley ,2007
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007
- Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Human vascular endothelial growth factor B: Characterization of recombinant isoforms and generation of neutralizing monoclonal antibodiesClinical and Experimental Pharmacology and Physiology, 2002
- Identification of the Major Intestinal Fatty Acid Transport ProteinMolecular Cell, 1999
- Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsProceedings of the National Academy of Sciences of the United States of America, 1998
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities: IMPLICATIONS FOR A FUNCTIONAL ROLE OF PLACENTA GROWTH FACTOR IN MONOCYTE ACTIVATION AND CHEMOTAXISPublished by Elsevier BV ,1996